TY - JOUR T1 - Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria JO - PharmacoEconomics UR - http://eprints.whiterose.ac.uk/101613/ PY - 2016/08/01 AU - Graham J AU - McBride D AU - Stull D AU - Halliday A AU - Alexopoulos ST AU - Balp M-M AU - Griffiths M AU - Agirrezabal I AU - Zuberbier T AU - Brennan A ED - DO - DOI: 10.1007/s40273-016-0412-1 VL - 34 IS - 8 SP - 815 EP - 827 Y2 - 2025/05/01 ER -